Sino Biological,Inc. (SHE:301047)

Market Cap	8.94B
Revenue (ttm)	616.62M
Net Income (ttm)	100.80M
Shares Out	121.64M
EPS (ttm)	0.80
PE Ratio	91.87
Forward PE	63.60
Dividend	1.00 (1.36%)
Ex-Dividend Date	May 20, 2025

Volume	1,337,745
Average Volume	1,989,852
Open	73.49
Previous Close	73.59
Day's Range	72.82 - 73.55
52-Week Range	53.51 - 87.82
Beta	1.04
RSI	56.01
Earnings Date	Aug 27, 2025

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers worldwide. It offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. The company also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine development, and multi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 1,021
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301047

Financial Performance

In 2024, Sino Biological,Inc.'s revenue was 613.67 million, a decrease of -5.06% compared to the previous year's 646.39 million. Earnings were 121.93 million, a decrease of -53.13%.